In this Policy Review, the Bone Working Group of the International Myeloma Working Group updates its clinical practice recommendations for the management of multiple myeloma-related bone disease. After assessing the available literature and grading recommendations using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) method, experts from the working group recommend zoledronic acid as the preferred bone-targeted agent for patients with newly diagnosed multiple myeloma, with or without multiple myeloma-related bone disease. Once patients achieve a very good partial response or better, after receiving monthly zoledronic acid for at least 12 months, the treating physician can consider decreasing the frequency of...
The European Myeloma Network provides recommendations for the management of the most common complica...
ABSTR ACT: Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM). More t...
textabstractThe European Myeloma Network provides recommendations for the management of the most com...
In this Policy Review, the Bone Working Group of the International Myeloma Working Group updates its...
Purpose The aim of the International Myeloma Working Group was to develop practice recommendations f...
Purpose The aim of the International Myeloma Working Group was to develop practice recommendations f...
PURPOSEThe aim of the International Myeloma Working Group was to develop practice recommendations fo...
PURPOSE: The aim of the International Myeloma Working Group was to develop practice recommendatio...
Multiple myeloma (MM) is a haematological malignancy characterised by the clonal proliferation of pl...
Multiple myeloma (MM) is a haematological malignancy characterised by the clonal proliferation of pl...
Purpose To update guideline recommendations on the role of bone-modifying agents in multiple myelom...
Design and methods: An interdisciplinary, expert panel of specialists on MM and myeloma-related bone...
Bone disease, including osteolytic lesions and/or osteoporosis, is a common feature of multiple myel...
Patients with multiple myeloma develop a devastating bone disease driven by the uncoupling of bone r...
The European Myeloma Network provides recommendations for the management of the most common complica...
The European Myeloma Network provides recommendations for the management of the most common complica...
ABSTR ACT: Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM). More t...
textabstractThe European Myeloma Network provides recommendations for the management of the most com...
In this Policy Review, the Bone Working Group of the International Myeloma Working Group updates its...
Purpose The aim of the International Myeloma Working Group was to develop practice recommendations f...
Purpose The aim of the International Myeloma Working Group was to develop practice recommendations f...
PURPOSEThe aim of the International Myeloma Working Group was to develop practice recommendations fo...
PURPOSE: The aim of the International Myeloma Working Group was to develop practice recommendatio...
Multiple myeloma (MM) is a haematological malignancy characterised by the clonal proliferation of pl...
Multiple myeloma (MM) is a haematological malignancy characterised by the clonal proliferation of pl...
Purpose To update guideline recommendations on the role of bone-modifying agents in multiple myelom...
Design and methods: An interdisciplinary, expert panel of specialists on MM and myeloma-related bone...
Bone disease, including osteolytic lesions and/or osteoporosis, is a common feature of multiple myel...
Patients with multiple myeloma develop a devastating bone disease driven by the uncoupling of bone r...
The European Myeloma Network provides recommendations for the management of the most common complica...
The European Myeloma Network provides recommendations for the management of the most common complica...
ABSTR ACT: Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM). More t...
textabstractThe European Myeloma Network provides recommendations for the management of the most com...